Efavir 600 mg Tablet

Efavir 600 mg Tablet contains efavirenz as its active ingredient at a strength of 600 mg per tablet. This is a non-nucleoside reverse transcriptase blocking agent used in the treatment of human immunodeficiency virus type 1 infection. The manufacturer is Cipla, India. Buyers looking for a reliable efavirenz 600 mg tablet supplier will find consistent product quality and stable availability through this listing.

What This Product Treats

Efavir 600 mg Tablet is used for human immunodeficiency virus type 1 infection in adults. It is used as part of combination antiretroviral regimens. The product covers both treatment-naive and treatment-experienced patient populations, making it a high-demand line for stockists supplying clinics, pharmacies, and distribution networks. Demand for this category is ongoing and consistent across markets.

How Efavirenz 600 mg Tablet Works in the Body

Efavirenz works by blocking the reverse transcriptase enzyme produced by the human immunodeficiency virus type 1. Reverse transcriptase is the enzyme the virus uses to convert its genetic material into DNA inside human cells. By blocking this enzyme directly without needing to be incorporated into the viral DNA chain. Efavirenz stops the virus from replicating. This is the defining action of the non-nucleoside reverse transcriptase blocking drug class. The compound binds to a specific site on the reverse transcriptase enzyme and locks it. Viral replication slows significantly as a result. It works.

Available Strengths and Pack Sizes

Efavir 600 mg Tablet is available in the following format:

• Strength: Efavirenz 600 mg per tablet

Pack size details beyond this strength are not listed in the current product specification. Buyers placing a bulk order for Efavir 600 mg should contact GetHIVTreatment directly for carton quantities, strip counts per box, and wholesale pack configurations. Strip-level and case-level pricing is available on request for resellers ordering in volume.

Side Effect

The side effect of efavirenz 600 mg tablet is well documented within this drug class. Commonly reported effects include central nervous system disturbances such as dizziness, difficulty sleeping, vivid dreams, and impaired concentration. These effects are typical of non-nucleoside reverse transcriptase blocking agents. Rash is reported in a portion of users and is a known characteristic of this compound. Less frequent effects include raised liver enzyme levels and mood changes.

The profile is consistent across branded and generic versions at this strength. Buyers stocking this product can expect the side effect profile to be stable and predictable. It is a well-characterized compound.

Shelf Life, Storage, and Packaging

Efavir 600 mg Tablet should be stored at controlled room temperature, generally below 30 degrees Celsius. The product must be kept away from direct sunlight and high humidity. Tablets are packaged in blister strips within a sealed carton. Shelf life for standard stock is typically 24 months from the date of manufacture, though buyers should verify the batch-specific expiry date at the time of ordering. These storage requirements are straightforward for standard pharmaceutical warehousing. No cold chain is needed. Stock rotation is simple at this shelf life.

Pricing and Availability

GetHIVTreatment carries the Efavir 600 mg Tablet for buyers ordering at the reseller and stockist level. Pricing per strip and per carton is available through the product listing. The unit cost at this strength positions efavirenz 600 mg tablet competitively within the non-nucleoside reverse transcriptase blocking category. Buyers comparing the Efavir 600 mg tablet price per strip against other suppliers will find the figures at this platform reflect bulk-oriented sourcing. This product is available for international ordering where applicable regulations permit.

Why Buyers Choose Efavir 600 mg Tablet

Efavirenz 600 mg tablet remains one of the most consistently ordered antiretroviral lines across wholesale and reseller channels. The compound has a long clinical history, which means demand is predictable and reorder cycles are stable. Cipla, India produces this product to established quality standards, giving buyers confidence in batch-to-batch consistency. Resellers buying Efavir 600 mg in bulk benefit from a product with strong market pull and a well-known identity among dispensing points.

The non-nucleoside reverse transcriptase blocking category as a whole holds a firm position in antiretroviral treatment programs globally. This makes it a dependable line to carry. Stock moves. Buyers reorder consistently.